TY - JOUR AU - Bacsur, Péter AU - Rutka, Mariann AU - Asbóth, András AU - Resál, Tamás AU - Szántó, Kata Judit AU - Jójárt, Boldizsár AU - Bálint, Anita AU - Ari, Eszter AU - Ajibola, Walliyulahi AU - Kintses, Bálint AU - Fehér, Tamás AU - Pigniczki , Daniella AU - Bor, Renáta AU - Fábián, Anna AU - Maléth, József AU - Szepes, Zoltán AU - Farkas, Klaudia AU - Molnár, Tamás TI - Effects of bowel cleansing on the composition of the gut microbiota in inflammatory bowel disease patients and healthy controls JF - THERAPEUTIC ADVANCES IN GASTROENTEROLOGY J2 - THER ADV GASTROENTER VL - 16 PY - 2023 PG - 13 SN - 1756-283X DO - 10.1177/17562848231174298 UR - https://m2.mtmt.hu/api/publication/34014839 ID - 34014839 N1 - "Asbóth Andrásnál tévesen szerepel a publikáción az SZTE/TTIK/BI/Biokémiai és Molekuláris Biológiai Tanszék. (SE, SZTE admin5)" LA - English DB - MTMT ER - TY - JOUR AU - Resál, Tamás AU - Mangó, Katalin AU - Bacsur, Péter AU - Szántó, Kata Judit AU - Pigniczki , Daniella AU - Keresztes, Csilla AU - Rutka, Mariann AU - Bálint, Anita AU - Milassin, Ágnes AU - Bor, Renáta AU - Fábián, Anna AU - Szepes, Zoltán AU - Farkas, Klaudia AU - Monostory, Katalin AU - Molnár, Tamás TI - Possible genetical predictors of efficacy and safety of budesonide-MMX in patients with mild-to-moderate ulcerative colitis, and safety comparison with methylprednisolone JF - EXPERT OPINION ON DRUG SAFETY J2 - EXPERT OPIN DRUG SAF VL - 22 PY - 2023 IS - 6 SP - 517 EP - 524 PG - 8 SN - 1474-0338 DO - 10.1080/14740338.2023.2181336 UR - https://m2.mtmt.hu/api/publication/33697762 ID - 33697762 N1 - Funding Agency and Grant Number: New National Excellence Program of the Ministry of Human Capacities [UNKP-22-3-SZTE-233, 125377, 129266, 134863, BO/00598/19/5]; Hungarian Scientific Research; National Research, Development and Innovation Office [BO/00723/22]; Janos Bolyai Research Grant; Geza Hetenyi Research Grant; Albert Szent-Gyoergyi Medical School, University of Szeged; [UNKP-22-3-SZTE-278]; [UNKP-22-5-SZTE-545]; [UNKP-22-4 -SZTE-296]; [UNKP-21-5-SZTE-552] Funding text: This work was supported by the research grants of the Hungarian Scientific Research (K22-143549) National Research, Development and Innovation Office (Grant ID: 125377, 129266 and 134863), by the New National Excellence Program of the Ministry of Human Capacities (UNKP-22-3-SZTE-278 to T Resal, UNKP-22-5-SZTE-545 to R Bor, UNKP-22-4 -SZTE-296 to A Fabian, UNKP-21-5-SZTE-552 to K Farkas, UNKP-22-3-SZTE-233 to P Bacsur), and Janos Bolyai Research Grant (BO/00598/19/5 to K Farkas and BO/00723/22 to R Bor) and the Geza Hetenyi Research Grant (to K Farkas, M Rutka and A Balint) by the Albert Szent-Gyoergyi Medical School, University of Szeged. LA - English DB - MTMT ER - TY - JOUR AU - Rutka, Mariann AU - Szántó, Kata Judit AU - Bacsur, Péter AU - Resál, Tamás AU - Jójárt, Boldizsár AU - Bálint, Anita AU - Ari, E AU - Kintses, B AU - Fehér, T AU - Asbóth, A AU - Pigniczki , Daniella AU - Bor, Renáta AU - Fábián, Anna AU - Farkas, Klaudia AU - Maléth, József AU - Szepes, Zoltán AU - Molnár, Tamás TI - Gut microbiota alterations after bowel preparation amongst inflammatory bowel disease patients JF - JOURNAL OF CROHNS & COLITIS J2 - J CROHNS COLITIS VL - 16 PY - 2022 IS - Suppl 1 SP - I609 EP - I609 PG - 1 SN - 1873-9946 DO - 10.1093/ecco-jcc/jjab232.834 UR - https://m2.mtmt.hu/api/publication/32615434 ID - 32615434 LA - English DB - MTMT ER - TY - JOUR AU - Farkas, Klaudia AU - Pigniczki , Daniella AU - Rutka, Mariann AU - Szántó, Kata Judit AU - Resál, Tamás AU - Bor, Renáta AU - Fábián, Anna AU - Szepes, Zoltán AU - Lázár, György ifj AU - Molnár, Tamás TI - The complex relationship between viruses and inflammatory bowel disease - review and practical advices for the daily clinical decision-making during the SARS-CoV-2 pandemic JF - THERAPEUTIC ADVANCES IN GASTROENTEROLOGY J2 - THER ADV GASTROENTER VL - 14 PY - 2021 PG - 13 SN - 1756-283X DO - 10.1177/1756284820988198 UR - https://m2.mtmt.hu/api/publication/32114368 ID - 32114368 N1 - Journal Article; Review AB - The coronavirus disease 2019 (COVID-19) outbreak emerged in December 2019 in China and rapidly spread worldwide. Inflammatory bowel disease (IBD) patients are likely to be more susceptible to viral infections, and this is significantly influenced by the type of therapy they receive. Thus, issues specifically concerning the medical treatment of IBD patients were shortly addressed at the beginning of the pandemic. However, recently available data on the occurrence and outcome of SARS-CoV-2 infection in IBD patients does not address the concerns raised at the beginning of the pandemic. Growing evidence and the rapid changes happening over the past few weeks have helped elucidate the current situation, contribute to our understanding of the disease, and many previously raised questions could now be answered. We hereby summarise available evidence regarding viral infections and IBD, focusing on SARS-CoV infections, and we provide practical recommendations related to patient management during the COVID-19 pandemic era. LA - English DB - MTMT ER - TY - JOUR AU - Rutka, Mariann AU - Pigniczki , Daniella AU - Molnár, Tamás TI - Tofacitinib Therapy, the Lender of Last Resort JF - JOURNAL OF CROHNS & COLITIS J2 - J CROHNS COLITIS VL - 15 PY - 2021 IS - 4 SP - 694 EP - 694 PG - 1 SN - 1873-9946 DO - 10.1093/ecco-jcc/jjaa198 UR - https://m2.mtmt.hu/api/publication/31891289 ID - 31891289 N1 - Funding Agency and Grant Number: National Research, Development and Innovation OfficeNational Research, Development & Innovation Office (NRDIO) - Hungary [125377, 129266]; Research Foundation of University of Szeged Hetenyi Geza Research Grant [5S581, 5S583]; Janos Bolyai Research GrantHungarian Academy of Sciences [BO/00598/19/5]; New National Excellence Program of the Ministry of Human Capacities [UNKP-19-4-SZTE-44] Funding text: This work was supported by the research grants of the National Research, Development and Innovation Office [grant ID: 125377 and 129266], the Research Foundation of University of Szeged Hetenyi Geza Research Grant [No. 5S581 and No. 5S583], and a Janos Bolyai Research Grant [BO/00598/19/5], New National Excellence Program of the Ministry of Human Capacities [UNKP-19-4-SZTE-44 to FK]. LA - English DB - MTMT ER - TY - JOUR AU - Bor, Renáta AU - Matuz, Mária AU - Fábián, Anna AU - Szepes, Zoltán AU - Szántó, Kata Judit AU - Farkas, Klaudia AU - Rutka, Mariann AU - Milassin, Ágnes AU - Pigniczki , Daniella AU - Bálint, Anita AU - Tóth, Tibor AU - Molnár, Tamás TI - Efficacy, tolerability and safety of a split-dose bowel cleansing regimen of magnesium citrate with sodium picosulfate - a phase IV clinical observational study JF - REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS J2 - REV ESP ENFERM DIG VL - 113 PY - 2021 IS - 9 SP - 635 EP - 642 PG - 8 SN - 1130-0108 DO - 10.17235/reed.2020.7073/2020 UR - https://m2.mtmt.hu/api/publication/31879053 ID - 31879053 LA - English DB - MTMT ER - TY - JOUR AU - Resál, Tamás AU - Szántó, Kata Judit AU - Pigniczki , Daniella AU - Rutka, Mariann AU - Bor, Renáta AU - Fábián, Anna AU - Szepes, Zoltán AU - Farkas, Klaudia AU - Nagy, Ferenc AU - Molnár, Tamás TI - Comparison of the effectiveness and safety of the vedolizumab therapy using in combination with or without cyclosporine in ulcerative colitis JF - UNITED EUROPEAN GASTROENTEROLOGY JOURNAL J2 - UEG JOURNAL VL - 8 PY - 2020 IS - S8 SP - 440 EP - 440 PG - 1 SN - 2050-6406 UR - https://m2.mtmt.hu/api/publication/32009631 ID - 32009631 LA - English DB - MTMT ER - TY - JOUR AU - Farkas, Klaudia AU - Szántó, Kata Judit AU - Kata, Diána AU - Földesi, Imre AU - Ferenci, Tamás AU - Rutka, Mariann AU - Pigniczki , Daniella AU - Bor, Renáta AU - Fábián, Anna AU - Szepes, Zoltán AU - Nagy, Ferenc AU - Molnár, Tamás TI - Faecal Monitoring is Useful in Monitoring Treatment Response in Anti-TNF-Treated Patients JF - JOURNAL OF CROHNS & COLITIS J2 - J CROHNS COLITIS VL - 14 PY - 2020 IS - Suppl 1 SP - S552 EP - S553 PG - 2 SN - 1873-9946 DO - 10.1093/ecco-jcc/jjz203.804 UR - https://m2.mtmt.hu/api/publication/32005128 ID - 32005128 LA - English DB - MTMT ER - TY - JOUR AU - Rutka, Mariann AU - Farkas, Klaudia AU - Pigniczki , Daniella AU - Szántó, Kata Judit AU - Bálint, Anita AU - Bor, Renáta AU - Fábián, Anna AU - Szepes, Zoltán AU - Nagy, Ferenc AU - Molnár, Tamás TI - Efficacy of tofacitinib in patients with ulcerative colitis after previous ineffective biological therapies JF - JOURNAL OF CROHNS & COLITIS J2 - J CROHNS COLITIS VL - 14 PY - 2020 IS - Suppl 1 SP - S545 EP - S546 PG - 2 SN - 1873-9946 DO - 10.1093/ecco-jcc/jjz203.791 UR - https://m2.mtmt.hu/api/publication/32005121 ID - 32005121 LA - English DB - MTMT ER - TY - JOUR AU - Pigniczki , Daniella AU - Szántó, Kata Judit AU - Rutka, Mariann AU - Farkas, Klaudia AU - Bálint, Anita AU - Bor, Renáta AU - Fábián, Anna AU - Szepes, Zoltán AU - Molnár, Tamás TI - Effects and safety of a colon-long absorbing budesonide product in patients with mild to moderate ulcerative colitis JF - JOURNAL OF CROHNS & COLITIS J2 - J CROHNS COLITIS VL - 14 PY - 2020 IS - Suppl 1 SP - S393 EP - S393 PG - 1 SN - 1873-9946 DO - 10.1093/ecco-jcc/jjz203.561 UR - https://m2.mtmt.hu/api/publication/32005068 ID - 32005068 LA - English DB - MTMT ER -